drugset / Trial / NCT02496143
A Safety and PK Study of EC-18 in Healthy Subjects
RandomizedSingle-groupQuadruple-blindSupportive care
Summary
The purpose of this study is to determine if EC-18 is safe and tolerable in healthy subjects.
Timeline
- Start
- 2015-07
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MOSEDIPIMOD | Small molecule | 500 mg | Oral |
| Subject | MOSEDIPIMOD | Small molecule | 1000 mg | Oral |
| Subject | MOSEDIPIMOD | Small molecule | 2000 mg | Oral |
| Subject | MOSEDIPIMOD | Small molecule | 4000 mg | Oral |